Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells
- 21 January 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 49 (20) , 2010-2012
Abstract
A DNA tetrahedron is employed for efficient delivery of doxorubicin into drug-resistant breast cancer cells. The drug delivered with the DNA nanoconstruct is considerably cytotoxic, whereas free doxorubicin is virtually non-cytotoxic for the drug-resistant cells. Thus, the DNA tetrahedron, made of the inherently natural and biocompatible material, can be a good candidate for the drug carrier to overcome MDR in cancer cells.Keywords
This publication has 15 references indexed in Scilit:
- Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer TherapyACS Nano, 2011
- DNA Cage Delivery to Mammalian CellsACS Nano, 2011
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistanceDrug Resistance Updates, 2011
- Site‐Specific Attachment of Proteins onto a 3D DNA Tetrahedron through Backbone‐Modified Phosphorothioate DNASmall, 2011
- Discovery and Development of Therapeutic AptamersAnnual Review of Pharmacology and Toxicology, 2010
- An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery PlatformAngewandte Chemie International Edition, 2006
- A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle SystemThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Rapid Chiral Assembly of Rigid DNA Building Blocks for Molecular NanofabricationScience, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005